Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Pipeline
IMMray™ Platform
Pipeline
Learn more
Lung cancer
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Social media
Media resources
Partnering
Contact Us
Subscribe
Immunovia Inc
English
Svenska
Press releases
Type
All types
Regulatory
Non regulatory
Year
All years
2022
2021
2020
2019
2018
2017
2016
2015
July 5, 2022
CPT PLA Code for the IMMray™ PanCan-d test approved
Read press release
June 30, 2022
The PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phase
Read press release
June 27, 2022
Invitation to Immunovia’s Presentation of PanFAM-1 Results
Read press release
June 27, 2022
| REGULATORY
PanFAM-1 Results Partly Inconclusive
Read press release
June 2, 2022
| REGULATORY
Philipp Mathieu appointed CEO of Immunovia AB
Read press release
May 23, 2022
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states
Read press release
May 17, 2022
Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states
Read press release
May 16, 2022
Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US
Read press release
April 28, 2022
| REGULATORY
Immunovia Publishes Interim Report January-March 2022
Read press release
April 21, 2022
Invitation to Immunovia’s Q1 presentation
Read press release
April 14, 2022
| REGULATORY
Immunovia CPT PLA Code submission for the IMMray™ PanCan-d test is on the agenda of American Medical Association
Read press release
April 7, 2022
| REGULATORY
Communiqué from the Annual General Meeting in Immunovia AB
Read press release
1
2
3
…
23
>
Home
Press releases